- Home
- MCR vs MRVI Comparison
MCR vs MRVI Comparison
Compare MCR & MRVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MCR
- MRVI
- Stock Information
- Founded
- MCR 1989
- MRVI 2014
- Country
- MCR United States
- MRVI United States
- Employees
- MCR N/A
- MRVI N/A
- Industry
- MCR Trusts Except Educational Religious and Charitable
- MRVI Biotechnology: Pharmaceutical Preparations
- Sector
- MCR Finance
- MRVI Health Care
- Exchange
- MCR Nasdaq
- MRVI Nasdaq
- Market Cap
- MCR 250.1M
- MRVI 262.9M
- IPO Year
- MCR N/A
- MRVI 2020
- Fundamental
- Price
- MCR $6.27
- MRVI $2.03
- Analyst Decision
- MCR
- MRVI Hold
- Analyst Count
- MCR 0
- MRVI 9
- Target Price
- MCR N/A
- MRVI $6.54
- AVG Volume (30 Days)
- MCR 66.7K
- MRVI 1.7M
- Earning Date
- MCR 01-01-0001
- MRVI 05-12-2025
- Dividend Yield
- MCR 8.52%
- MRVI N/A
- EPS Growth
- MCR N/A
- MRVI N/A
- EPS
- MCR 0.38
- MRVI N/A
- Revenue
- MCR N/A
- MRVI $259,185,000.00
- Revenue This Year
- MCR N/A
- MRVI N/A
- Revenue Next Year
- MCR N/A
- MRVI $14.23
- P/E Ratio
- MCR $16.61
- MRVI N/A
- Revenue Growth
- MCR N/A
- MRVI N/A
- 52 Week Low
- MCR $5.63
- MRVI $1.67
- 52 Week High
- MCR $6.70
- MRVI $11.56
- Technical
- Relative Strength Index (RSI)
- MCR 60.46
- MRVI 47.81
- Support Level
- MCR $6.17
- MRVI $1.96
- Resistance Level
- MCR $6.31
- MRVI $2.16
- Average True Range (ATR)
- MCR 0.05
- MRVI 0.12
- MACD
- MCR 0.02
- MRVI 0.05
- Stochastic Oscillator
- MCR 87.20
- MRVI 69.77
About MCR MFS Charter Income Trust
MFS Charter Income Trust is a United States-based closed-end fund. Its investment objective is to seek high current income, but may also consider capital appreciation. The fund invests the assets in Debt Instruments, Corporate Bonds, U.S. Government Securities, Foreign Government Securities, Securitized Instruments, Derivatives, Principal Risks, Debt Management Risk, Investment Selection Risk, Interest Rate Risk, Credit Risk, Foreign Risks, Emerging Markets Risk, Currency Risk, Leveraging Risk, Operational and Cybersecurity Risk, Active and Frequent Trading, and etc of different market countries.
About MRVI Maravai LifeSciences Holdings Inc.
Maravai LifeSciences Holdings Inc is a life sciences company that provides critical products that drive the development of groundbreaking vaccines, drug therapies, cell and gene therapies, and diagnostics. The group's solutions empower research into human diseases and support the entire biopharmaceutical development process from early discovery to commercialization. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.